Literature DB >> 24119539

Defensin-based anti-infective strategies.

Miriam Wilmes1, Hans-Georg Sahl2.   

Abstract

Cationic and amphiphilic peptides are widely distributed in eukaryotic organisms and constitute a first line of host defense against invading pathogens. Some of these host defense peptides (HDPs) combine specific antibiotic activities with modulation of immune responses. Moreover, they are active against bacteria resistant to conventional antibiotics and show only modest resistance development under in vitro selection pressure. Based on these features, HDPs and particularly defensins are considered a promising source of novel anti-infective agents. This review summarizes the current knowledge about defensins from different kingdoms and discusses their potential for therapeutic application.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Keywords:  Antimicrobial peptides; Defensins; Host defense peptides; Immunomodulation; Target-mediated antibiotic activity

Mesh:

Substances:

Year:  2013        PMID: 24119539     DOI: 10.1016/j.ijmm.2013.08.007

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  23 in total

1.  Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5.

Authors:  Haritha R Chileveru; Shion A Lim; Phoom Chairatana; Andrew J Wommack; I-Ling Chiang; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2015-03-02       Impact factor: 3.162

2.  Protective efficacy of a Salmonella Typhimurium ghost vaccine candidate constructed with a recombinant lysozyme-PMAP36 fusion protein in a murine model.

Authors:  Ja Young Moon; So Young Kim; Won Kyong Kim; Zhili Rao; Jung Hee Park; Ji Young Mun; Boram Kim; Hyo Sun Choi; Jin Hur
Journal:  Can J Vet Res       Date:  2017-10       Impact factor: 1.310

Review 3.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

Review 4.  Development of protein mimics for intracellular delivery.

Authors:  Brittany M deRonde; Gregory N Tew
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

Review 5.  Emerging and future strategies in the management of recalcitrant Candida auris.

Authors:  Nihal Bandara; Lakshman Samaranayake
Journal:  Med Mycol       Date:  2022-03-17       Impact factor: 4.076

6.  Protective efficacy of the recombinant lysozyme-PMAP36 fusion protein-inactivated Salmonella Typhimurium vaccine candidate via oral immunization in a murine model.

Authors:  Jayoung Moon; Soyoung Kim; Wonkyong Kim; Zhili Rao; Junghee Park; Byungyong Park; Jin Hur
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

7.  Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.

Authors:  Virginia Basso; Angie Garcia; Dat Q Tran; Justin B Schaal; Patti Tran; Diana Ngole; Younus Aqeel; Prasad Tongaonkar; André J Ouellette; Michael E Selsted
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

8.  Killing of staphylococci by θ-defensins involves membrane impairment and activation of autolytic enzymes.

Authors:  Miriam Wilmes; Marina Stockem; Gabriele Bierbaum; Martin Schlag; Friedrich Götz; Dat Q Tran; Justin B Schaal; André J Ouellette; Michael E Selsted; Hans-Georg Sahl
Journal:  Antibiotics (Basel)       Date:  2014

Review 9.  Adjuvants: friends in vaccine formulations against infectious diseases.

Authors:  G G Guerrero Manriquez; I Tuero
Journal:  Hum Vaccin Immunother       Date:  2021-07-21       Impact factor: 4.526

Review 10.  Antimicrobial Peptides in Human Sepsis.

Authors:  Lukas Martin; Anne van Meegern; Sabine Doemming; Tobias Schuerholz
Journal:  Front Immunol       Date:  2015-08-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.